Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene therapy by administration of genetically engineered CD34+ cells obtained from cord blood

Gene therapy by administration of genetically engineered CD34+ cells obtained from cord blood

US Patent 6984379 · Granted Jan 10, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene editing of monogenic disorders in human hematopoietic stem cells—correction2025
Self-inactivating lentiviral vector comprising a FOXP3 expression cassette2024
Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies2024
Method for treating adenosine deaminase severe combined imunodeficiency2020
Gene therapy2007
Method for cloning of a rare, specifically mutated cell2005
Transgenomic viruses2001
Bystander effect tumoricidal therapy by expressing an HSV-tk gene2000
Retroviral vectors for expression in embryonic cells1998
Cytosine deaminase negative selection system for gene transfer techniques and th1997
Cytosine deaminase negative selection system for gene transfer techniques and th1997
Gene therapy1995